Position in PFE
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,369,405
-$64,837 QoQ
Shares Held
56,869
+11.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,136
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Formidable Asset Management, LLC holds $28,439,814 across 10 Drug Manufacturers - General names. PFE ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,607 | $13,921,785 | |
| 2 | JNJ |
Johnson & Johnson
|
23,878 | $6,064,295 | |
| 3 | ABBV |
AbbVie Inc.
|
9,748 | $2,452,986 | |
| 4 | AMGN |
Amgen Inc
|
5,152 | $1,865,642 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,070 | $1,422,495 | |
| 6 | PFE |
Pfizer Inc
This page
|
56,869 | $1,369,405 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,040 | $520,884 | |
| 8 | NVS |
Novartis AG
|
2,430 | $380,829 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,369,405 | 56,869 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $1,434,242 | 51,077 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,156,480 | 46,445 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,293,721 | 50,774 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,334,775 | 55,065 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,395,347 | 55,065 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,554,392 | 58,590 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $1,710,267 | 59,097 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,660,053 | 59,330 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,748,472 | 63,008 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,860,064 | 64,608 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,314,005 | 69,762 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,490,241 | 67,891 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,816,742 | 44,528 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,280,743 | 44,511 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,964,736 | 44,898 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,348,025 | 44,784 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $2,312,255 | 44,664 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,699,175 | 45,710 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,976,223 | 45,948 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,814,791 | 46,343 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,797,406 | 49,611 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,847,530 | 50,191 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $1,801,124 | 49,077 | Shares | Sole | 2020-12-14 | |
| 2020-06-30 | $1,584,807 | 48,465 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,451,009 | 44,455 | Shares | Sole | 2020-06-01 | |
| No filing history on record for this holder in this stock. | ||||||